Quality of Life and Psychosocial Impact in Adults with Genetic Lipodystrophy
Overview
This study assessed 109 adults with genetic lipodystrophy, revealing significantly reduced physical and mental health-related quality of life compared to the general population. High rates of depression, chronic pain, social discrimination, and negative body image were reported, underscoring substantial psychosocial burden.
Background
Genetic lipodystrophy syndromes are rare multisystemic disorders characterized by abnormal fat distribution and severe metabolic complications such as insulin resistance and cardiometabolic disease. These conditions often lead to diagnostic delays and multispecialty care needs. The physical morphotype and metabolic complications can negatively affect patients' psychological well-being and social functioning. Prior research on quality of life and social impact has been limited by small sample sizes and incomplete assessment of social and psychological domains.
Data Highlights
Measure
Finding
Sample size
109 adults with genetic lipodystrophy (93 FPLD, 16 CGL)
Gender distribution
84% women
Health-related quality of life
Significantly decreased physical and mental scores vs. general population (P < .001)
Depression prevalence
41% reported moderate or severe depression
Chronic pain
69% reported chronic pain
Use of psychotropic medications
50% had taken tranquilizers, sleeping pills, or antidepressants
Social discrimination
73% experienced discrimination; 34% from health professionals
Unemployment due to health
Higher in female patients compared to general population
Negative impact on body image (women)
More than 50% reported very negative impact, associated with depressive symptoms
Key Findings
Adults with genetic lipodystrophy have significantly lower physical and mental health-related quality of life compared to age- and gender-matched general population norms.
41% of patients reported moderate to severe depression, and 69% suffered from chronic pain, indicating substantial psychological and physical symptom burden.
Half of the respondents have used psychotropic medications such as tranquilizers, sleeping pills, or antidepressants during their lifetime.
Social discrimination is highly prevalent, affecting 73% of patients, with over one-third of discrimination originating from healthcare professionals.
Female patients are more frequently unemployed due to health issues compared to the general population, highlighting socioeconomic impact.
Negative body image is common, especially among women, and is significantly associated with depressive symptoms.
Clinical Implications
Clinicians should recognize the profound psychosocial and physical burden experienced by patients with genetic lipodystrophy, including high rates of depression, chronic pain, and social discrimination. Integrated care approaches incorporating psychological support and targeted therapeutic education are essential. Awareness and training for healthcare professionals may reduce discrimination and improve patient outcomes.
Conclusion
Genetic lipodystrophy significantly impairs quality of life, psychological health, and social functioning. Multidisciplinary care addressing both physical and psychosocial needs is critical to improving patient well-being.
References
French National Reference Network for Rare Diseases of Insulin Secretion and Insulin Sensitivity (PRISIS) -- Quality of Life, Social Interaction, and Psychological Health in 109 Adults Diagnosed with Genetic Lipodystrophy
